328 related articles for article (PubMed ID: 29057524)
1. Organ transplantation from "increased infectious risk donors": the experience of the Nord Italia Transplant program - A retrospective study.
Grossi PA; Dalla Gasperina D; Lombardi D; Ricci A; Piccolo G; Nanni Costa A
Transpl Int; 2018 Feb; 31(2):212-219. PubMed ID: 29057524
[TBL] [Abstract][Full Text] [Related]
2. Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: Retrospective analysis of disease transmission and safety.
Irwin L; Kotton CN; Elias N; Palafox J; Basler D; Shao SH; Lester W; Zhang X; Kimball B; Trencher C; Fishman JA
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28994164
[TBL] [Abstract][Full Text] [Related]
3. Organ utilization from increased infectious risk donors: An observational study.
L'Huillier AG; Humar A; Payne C; Kumar D
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28981193
[TBL] [Abstract][Full Text] [Related]
4. Screening recipients of increased risk donor organs: A multicenter retrospective study.
Ison MG; Rana MM; Brizendine KD; Chimienti S; Le J; Kfoury R; Mohazabnia P; Theodoropoulos N
Transpl Infect Dis; 2018 Jun; 20(3):e12862. PubMed ID: 29512233
[TBL] [Abstract][Full Text] [Related]
5. Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020.
Jones JM; Kracalik I; Levi ME; Bowman JS; Berger JJ; Bixler D; Buchacz K; Moorman A; Brooks JT; Basavaraju SV
MMWR Recomm Rep; 2020 Jun; 69(4):1-16. PubMed ID: 32584804
[TBL] [Abstract][Full Text] [Related]
6. Deceased Organ Donors and PHS Risk Identification: Impact on Organ Usage and Outcomes.
Pruett TL; Clark MA; Taranto SE
Transplantation; 2017 Jul; 101(7):1670-1678. PubMed ID: 28252560
[TBL] [Abstract][Full Text] [Related]
7. Screening recipients of increased-risk donor organs: a survey of transplant infectious diseases physician practices.
Theodoropoulos N; Ladner DP; Ison MG
Transpl Infect Dis; 2013 Oct; 15(5):545-9. PubMed ID: 23901896
[TBL] [Abstract][Full Text] [Related]
8. Utilizing increased risk for disease transmission (IRD) kidneys for pediatric renal transplant recipients.
Hwang CS; Gattineni J; MacConmara M
Pediatr Nephrol; 2019 Oct; 34(10):1743-1751. PubMed ID: 31243535
[TBL] [Abstract][Full Text] [Related]
9. Deceased organ donor screening for HIV, hepatitis B, and hepatitis C viruses: a survey of organ procurement organization practices.
Theodoropoulos N; Jaramillo A; Ladner DP; Ison MG
Am J Transplant; 2013 Aug; 13(8):2186-90. PubMed ID: 23711196
[TBL] [Abstract][Full Text] [Related]
10. Impact of US Public Health Service increased risk deceased donor designation on organ utilization.
Sapiano MRP; Jones JM; Bowman J; Levi ME; Basavaraju SV
Am J Transplant; 2019 Sep; 19(9):2560-2569. PubMed ID: 30959569
[TBL] [Abstract][Full Text] [Related]
11. Excerpt from PHS guideline for reducing HIV, HBV and HCV transmission through organ transplantation.
Seem DL; Lee I; Umscheid CA; Kuehnert MJ
Am J Transplant; 2013 Aug; 13(8):1953-62. PubMed ID: 23890284
[TBL] [Abstract][Full Text] [Related]
12. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B and C virus infections transmitted through organ transplantation investigated by CDC, United States, 2014-2017.
Bixler D; Annambholta P; Abara WE; Collier MG; Jones J; Mixson-Hayden T; Basavaraju SV; Ramachandran S; Kamili S; Moorman A
Am J Transplant; 2019 Sep; 19(9):2570-2582. PubMed ID: 30861300
[TBL] [Abstract][Full Text] [Related]
14. Public health safety and transplant with increased-risk organs: striking the balance.
Batra R; Katariya N; Hewitt W; Mathur A; Reddy S; Moss A; Segev D; Singer A
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():9-12. PubMed ID: 25894120
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of high-risk donor organs: a survey of US solid organ transplant center practices as reported by transplant infectious diseases physicians.
Ison MG; Stosor V
Clin Transplant; 2009; 23(6):866-73. PubMed ID: 19473202
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center.
Burton CE; Doucette KE; Mabilangan CA; Plitt SS; Lee BE; Preiksaitis JK
Transpl Infect Dis; 2016 Aug; 18(4):520-8. PubMed ID: 27226204
[TBL] [Abstract][Full Text] [Related]
17. Utilization of deceased organ donors based on HIV, hepatitis B virus, and hepatitis C virus screening test results.
Theodoropoulos N; Kroll-Desrosiers A; Ison MG
Transpl Infect Dis; 2020 Aug; 22(4):e13275. PubMed ID: 32144838
[TBL] [Abstract][Full Text] [Related]
18. A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group.
Pereira BJ; Wright TL; Schmid CH; Levey AS
Lancet; 1995 Feb; 345(8948):484-7. PubMed ID: 7532254
[TBL] [Abstract][Full Text] [Related]
19. Impact of repeat testing of living kidney donors within 14 days of the transplant procedure: a multicenter retrospective survey.
Echenique IA; Cohen D; Rudow DL; Ison MG
Transpl Infect Dis; 2014 Jun; 16(3):403-11. PubMed ID: 24796964
[TBL] [Abstract][Full Text] [Related]
20. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage.
Fabrizio F; Bunnapradist S; Martin P
J Nephrol; 2002; 15(6):605-13. PubMed ID: 12495272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
